Loading clinical trials...
Loading clinical trials...
A randomized, multicenter study comparing the safety and efficacy of CT-ACL001, a regenerative ligament, with standard treatment in anterior cruciate ligament reconstruction
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CoreTissue BioEngineering Inc.
Collaborators
NCT05501210 · Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, and more
NCT07333092 · Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
NCT07043569 · ACL - Anterior Cruciate Ligament Rupture
NCT06973785 · ACL - Anterior Cruciate Ligament Rupture, ACL Injuries
NCT07023653 · Anterior Cruciate Ligament Rupture
Hirosaki University Hospital
Hirosaki, Aomori
Hiroshima University Hospital
Hiroshima, Hiroshima
Hokkaido University Hospital
Sapporo, Hokkaido
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions